Feng Qiang, Zhang Lu, Liu Chao, Li Xuanyu, Hu Guoqing, Sun Jiashu, Jiang Xingyu
Beijing Engineering Research Center for BioNanotechnology and CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety , National Center for NanoScience and Technology, Beijing 100190, China.
LNM, Institute of Mechanics , Chinese Academy of Sciences, Beijing 100190, China.
Biomicrofluidics. 2015 Jun 23;9(5):052604. doi: 10.1063/1.4922957. eCollection 2015 Sep.
Core-shell hybrid nanoparticles (NPs) for drug delivery have attracted numerous attentions due to their enhanced therapeutic efficacy and good biocompatibility. In this work, we fabricate a two-stage microfluidic chip to implement a high-throughput, one-step, and size-tunable synthesis of mono-disperse lipid-poly (lactic-co-glycolic acid) NPs. The size of hybrid NPs is tunable by varying the flow rates inside the two-stage microfluidic chip. To elucidate the mechanism of size-controllable generation of hybrid NPs, we observe the flow field in the microchannel with confocal microscope and perform the simulation by a numerical model. Both the experimental and numerical results indicate an enhanced mixing effect at high flow rate, thus resulting in the assembly of small and mono-disperse hybrid NPs. In vitro experiments show that the large hybrid NPs are more likely to be aggregated in serum and exhibit a lower cellular uptake efficacy than the small ones. This microfluidic chip shows great promise as a robust platform for optimization of nano drug delivery system.
用于药物递送的核壳杂化纳米粒子(NPs)因其增强的治疗效果和良好的生物相容性而备受关注。在这项工作中,我们制造了一种两级微流控芯片,以实现单分散脂质-聚(乳酸-乙醇酸)纳米粒子的高通量、一步法和尺寸可调合成。通过改变两级微流控芯片内部的流速,可以调节杂化纳米粒子的尺寸。为了阐明杂化纳米粒子尺寸可控生成的机制,我们用共聚焦显微镜观察微通道内的流场,并通过数值模型进行模拟。实验和数值结果均表明,在高流速下混合效果增强,从而导致小尺寸且单分散的杂化纳米粒子的组装。体外实验表明,大尺寸的杂化纳米粒子在血清中更易聚集,并且与小尺寸的相比,其细胞摄取效率较低。这种微流控芯片作为优化纳米药物递送系统的强大平台具有巨大潜力。